Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $452.35, marking a +2.11% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.01%. On the other hand, the Dow registered a gain of 0.51%, and the technology-centric Nasdaq decreased by 0.28%. Shares of the company have depreciated by 2.53% over the course of the past month, underperforming the Medical sector's gain of 4.67%, and the S&P 500's gain of 4.83%.The investment community will be paying close attention to the earnings performance of Intuitive Surgical, Inc. in its upcoming release. The company is predicted to post an EPS of $1.99, indicating a 8.15% growth compared to the equivalent quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $2.41 billion, reflecting a 18.2% rise from the equivalent quarter last year. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $8.17 per share and revenue of $9.78 billion, indicating changes of +11.31% and +17.06%, respectively, compared to the previous year. Investors might also notice recent changes to analyst estimates for Intuitive Surgical, Inc. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.03% decrease. Intuitive Surgical, Inc. is currently a Zacks Rank #4 (Sell). In the context of valuation, Intuitive Surgical, Inc. is at present trading with a Forward P/E ratio of 54.23. For comparison, its industry has an average Forward P/E of 24.05, which means Intuitive Surgical, Inc. is trading at a premium to the group. Investors should also note that ISRG has a PEG ratio of 3.72 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Medical - Instruments industry had an average PEG ratio of 2.5. The Medical - Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 81, finds itself in the top 33% echelons of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions. Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks